Results 81 to 90 of about 49,152 (197)

Acute pseudogout after pamidronate infusion.

, 2008
International audienceA 72-year-old man, treated with a 60-mg intravenous infusion of pamidronate for shoulder hand syndrome, developed after few hours an acute pseudogout arthritis of his right knee.
Griffond, Vincent, Tisserand, Guillaume, Saccomani, Clarisse, Wendling, Daniel, Toussirot, Eric   +4 more
core   +1 more source

Successful treatment of calciphylaxis with pamidronate

, 2015
Calciphylaxis is a complication of chronic kidney disease characterized by necrotic lesion in the skin. Histological examination reveals microcalcification of medium-sized blood vessels.
Hooman, N., Naghshi-Zadiyan, R., Mehrazma, M., Jahangiri, F.   +3 more
core  

Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate.

, 2001
Collapsing focal segmental glomerulosclerosis (FSGS) is a distinct clinicopathologic entity seen most commonly in young African American patients who present with renal insufficiency and nephrotic syndrome. The only epidemiologic factor previously linked
Markowitz, Glen S, Kuhn, Joseph A, Dratch, Adam D, D\u27Agati, Vivette D, Appel, Gerald B, Fine, Paul L, Fenves, Andrew Z, Loon, Nicholas R, Jagannath, Sundar   +8 more
core   +1 more source

Influence of zoledronic acid and pamidronate on tooth eruption in children with osteogenesis imperfecta

Introduction: Osteogenesis imperfecta (OI) is a congenital disease comprising a heterogeneous group of inherited connective tissue disorders. The main treatment in children is bisphosphonate therapy.
Nova García, Manuel Joaquín De, Del Río Cantero, Natalia, Sagastizábal Cardelús, Belén, Mourelle Martínez, Rosa   +3 more
core   +1 more source

Pamidronate induces modifications of circulating angiogenetic factors in cancer patients

, 2002
Purpose: Recently, new experimental data suggested that, besides inhibiting osteoclasts, bisphosphonate may also have an antitumor effect. Antiangionetetic activity is one of the possible mechanisms of anticancer activity attributed to bisphosphonates ...
Dicuonzo G, Denaro V, Battistoni F, Gavasci M, Avvisati G, Santini D, Vincenzi B, Salerno A, Tonini G   +8 more
core  

Pamidronate in the prevention of bone loss after liver transplantation: a randomized controlled trial

, 2009
: Rapid bone loss and high rates of fractures occur following liver transplantation. To analyze the effect of intravenous pamidronate on bone loss after liver transplantation. A randomized, double-blind, placebo-controlled study was performed.
Casafont, F, Monegal, A, Guañabens, N, Suárez, MJ, De la Mata, M, Serrano, T, Barrios, C, Suárez, F, García-González, M, Clemente, G, Tome, S, Navasa, M.   +11 more
core   +1 more source

The clinical and radiological assessment of cyclic intravenous pamidronate administration in children with osteogenesis imperfecta

The Turkish Journal of Pediatrics, 2004
Over the past 20 years, orally administered biphosphonates have been used extensively in the management of a number of common skeletal disorders of different etiology.
Pelin Adiyaman, Gönül Ocal, Merih Berberoğlu, Olcay Evliyaoğlu, Zehra Aycan, Ergun Cetinkaya   +5 more
doaj  

A Novel Method to Study Hip Growth and Development in Children with Cerebral Palsy

Children
Background: Knowledge of the relative contributions to different growth areas in the proximal femur and acetabulum is limited due to the complex anatomy and lack of growth markers in children.
Luiz Carlos Almeida da Silva, Yusuke Hori, Burak Kaymaz, Jason J. Howard, Arianna Trionfo, Michael Wade Shrader, Freeman Miller   +6 more
doaj   +1 more source

Analysis of Series of Cases of Fibrous Dysplasia of Proximal Femur in Pediatric Population

Journal of Orthopaedic Case Reports
Introduction: Fibrous dysplasia (FD) accounts for 5–7% of all benign bone tumors. It presents in two main forms – monostotic, which is more common affecting a single bone and presenting usually in 3rd decade of life; polyostotic, affecting several bones,
Sumit Gupta, Ankur Agarwal, Lokesh Raghav, Shray Jain, Amit Kumar Gupta   +4 more
doaj   +1 more source

Intravenous pamidronate reduces osteoporosis and improves formation of the regenerate during distraction osteogenesis

, 2001
We examined the effect on bone mineral density (BMD) of a single dose of 3 mg/kg of the bisphosphonate, pamidronate (Novartis) in distraction osteogenesis in immature rabbits.
D. G. Little, C. T. Cowell, M. S. Cornell, C. M. Cooke-Yarborough, S. Arbuckle, J. Briody   +5 more
core   +1 more source